Episode 1: Prostate Cancer’s New Hope: RLT in Action - Global focus

This first episode of the RLT Channel series is designed for individuals living with prostate cancer and their loved ones. Its goal is to demystify radioligand therapy (RLT) for prostate cancer by offering clear and practical information, helping you understand how the therapy works, its potential benefits, and how it can be integrated into the care pathway. The RLT Channel is evolving into one of our key initiatives, offering a recurring platform to spotlight various cancers and explore their treatment possibilities through radiotheranostics. Each program is designed to provide comprehensive insights, from addressing global challenges to highlighting local perspectives and advancements. 00:00 Prostate Cancer’s New Hope: RLT in Action 00:11 Rebecca Lo bue, the Oncidium foundation Introduction 02:28 Prof. Zena Wimana, University Hospital of Brussels (H.U.B.) – Jules Bordet Institute What is Radioligand Therapy (RLT)? 11:16 Prof. Dr. Nadia Withofs, CHU Liege When is RLT an option? 15:24 Dr. John-Antoine (Egypt) and Mr. Butler (USA) The patient journey with RLT: what to expect? 22:18 Dr. Vincent Vanhaudenarde, CHU UCL Namur Supportive care: Enhancing the treatment experience 30:07 Dr. Erik Briers, Europa Uomo & Wij Ook vzw RLT: Understanding Access and Challenges 40:49 Rebecca Lo bue, the Oncidium foundation The Oncidium foundation: Patient-centered actions 41:39: Rebecca Lo bue, the Oncidium foundation Key messages